Product regulatory systems in low-and middle-income countries must be strengthened

October 23, 2012

When regulatory systems for medical products in low-and middle-income countries work, people live but when such systems fail, people die, according to experts from the US Food and Drug Administration (FDA) writing in this week's PLOS Medicine.

Charles Preston, Mary Lou Valdez, and Katherine Bond from the Office of International Programs at the FDA, argue that few global initiatives focus on strengthening the medical product regulatory systems in low-and middle-income countries but that globalization and the scaling up of medicines and vaccines to these countries are highlighting the urgent need for systems to assure product efficacy, safety, and quality.

Using recent examples, such as the successful MenAfriVac (a vaccine against meningitis designed for ), the authors argue that although the global health community is gradually awakening to the role that regulatory systems play in low- and middle-income countries, more needs to be done to make strengthening these systems a global health priority.

The authors propose several elements that all regulatory systems, whether in high, middle, or low-income countries should have, such as firm rules and a mechanism to take regulatory action when necessary. They say: "To this end, it will be important to begin a global dialogue on the subject of strengthening in low- and middle-income countries."

The authors conclude: "As the challenges of globalization mount, and efforts to provide medical products to low- and middle-income countries scale up, there is no better time to put regulatory system strengthening squarely on the and development agenda."

Explore further: How health systems factors affect access to psychotropic medicines

More information: PLoS Med 9(10): e1001327. doi:10.1371/journal.pmed.1001327

Related Stories

Time to invest in trauma care

March 19, 2012

Up to two million lives, annually, could be saved globally with improvements in trauma care, particularly in low- and middle-income countries. This estimate by Charles Mock, from the University of Washington in Seattle, and ...

Obesity linked to economic status in developing countries

July 18, 2012

(HealthDay) -- In low- and middle-income developing countries, socioeconomic status (SES) plays an important role in the development of obesity, particularly in women, according to research published online July 5 in Obesity ...

Recommended for you

Rio athletes may benefit from 'leaky gut' therapy

June 29, 2016

'Leaky gut' is a condition where the thin mucosal barrier of the gut, which plays a role in absorbing nutrients and preventing large molecules and germs from the gut entering the blood stream, becomes less effective.

Doctors swamped by 'e-medicine' demands

June 29, 2016

(HealthDay)—Doctors say they're drowning in electronic paperwork, feeling burned out and dissatisfied with their jobs thanks to countless hours spent filling out computerized medical forms, researchers report.

E-cigarette vapors could be toxic to mouth, study finds

June 28, 2016

A new UCLA study suggests that e-cigarettes may not be significantly safer than tobacco cigarettes. The research, which was conducted on cultured cells, found that e-cigarettes contain toxic substances and nanoparticles that ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.